Kevin Kwaku
Cardiovascular Disease · Lebanon, NHNPI 1619956968
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $53,529 of the $78,638 with a category attached, or 68.1%. Biosense Webster, Inc. accounts for 63.3% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $24,043 and has fallen 69.1% since, to $7,435 in 2025. Among cardiovascular disease clinicians in NH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 124 payments — averaging $634.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biosense Webster, Inc.$50K
- Janssen Scientific Affairs, LLC$11K
- Altathera Pharmaceuticals LLC$8K
- Medical Device Business Services, Inc.$4K
- Medtronic$3K
- Boston Scientific$2K
- plus $513 from 3 others
Across 58 payments — averaging $2702.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$157K
What the payments were for
- Consulting fees$53,52968%
- Speaking & faculty fees$2,2503%
- Travel & lodging$18,55524%
- Food & beverage$4,3035%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biosense Webster, Inc. | 53 | $49,739 |
| Janssen Scientific Affairs, LLC | 14 | $10,577 |
| Altathera Pharmaceuticals LLC | 5 | $8,255 |
| Medical Device Business Services, Inc. | 7 | $4,401 |
| Medtronic | 23 | $2,821 |
| Boston Scientific | 15 | $2,332 |
| Abbott | 5 | $259 |
| Elutia, Inc. | 1 | $137 |
| Novo Nordisk | 1 | $117 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$39,186
- Sotalol Hydrochloride$8,233
- ARCTIC FRONT ADVANCE$758
- CARDIOBLATE CRYOFLEX$443
- Thermocool SF$314
- GENERAL - THERAPIES$150
- XARELTO$149
- ECM Patch,Pouch$137
- Farapulse$122
- Micra$118
How this compares
$78,638 in reported general payments places this provider in the 95th percentile of 112 cardiovascular disease providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 104 | $89,288 |
| XareltoRivaroxaban | 16 | $24,991 |
| MultaqDronedarone Hcl | 20 | $23,456 |
| Dofetilide | 24 | $4,414 |
| Metoprolol Succinate | 81 | $1,796 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 12 | $498 |
| Diltiazem 24hr ErDiltiazem Hcl | 15 | $461 |
| Flecainide Acetate | 13 | $346 |
| Digoxin | 18 | $293 |
| Losartan Potassium | 15 | $207 |
| Metoprolol Tartrate | 17 | $175 |
| Lisinopril | 11 | $128 |
| Amlodipine Besylate | 20 | $99 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Lebanon
- Michael YoungLebanon$53K
- Merle MyersonLebanon$15K
- Ian GilchristLebanon$13K
- Robert DangeloLebanon$10K
- Rumman SyedLebanon$9K
- Mohammadtokir MujtabaLebanon$8K
- Lauren Gilstrap MilleyLebanon$5K
- Fernando Contreras-ValdesLebanon$5K
- David MinLebanon$3K
- Monika BernasLebanon$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.